# FDA Warning Letter: Thrasio, LLC D/B/A ZymaDerm
> 2023-08-22 · Center for Drug Evaluation and Research | CDER · `cdac7fc9ac667c7a`
## Letter
- **Company:** Thrasio, LLC D/B/A ZymaDerm
- **Posted Date:** 2023-08-22
- **Letter Issue Date:** 2023-08-18
- **Issuing Office:** Center for Drug Evaluation and Research | CDER
## Subject
Unapproved New Drugs/Misbranded
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*